Skip to content

Clinical trials

Terminated Phase 2/3 trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 2/3 Status: Terminated Country / region: China Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20092
20114
20122
20142
20162
20172
20184
20192
20203
20216
20224
20232
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated39

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong2
Fudan University2
Peking University2
Sun Yat-sen University2
Suzhou Suncadia Biopharmaceuticals Co., Ltd.2
Aerovate Therapeutics1
Bio-Thera Solutions1
Boehringer Ingelheim1
Bristol-Myers Squibb1
Capital Medical University1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Hepatocellular3
Endometrial Neoplasms3
Colorectal Neoplasms2
Acute Kidney Injury1
Alzheimer Disease1
Biliary Atresia1
Biliary Tract Neoplasms1
COVID-191
Camurati-Engelmann Syndrome1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 25 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.